By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Acutus Medical, Inc.

Acutus Medical, Inc. (AFIB)

OTC Currency in USD
$0.00
$0.00
+20.00%
Last Update: 3 Sept 2025, 18:42
$17.95K
Market Cap
-0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.22
52 Week Range

AFIB Stock Price Chart

Explore Acutus Medical, Inc. interactive price chart. Choose custom timeframes to analyze AFIB price movements and trends.

AFIB Company Profile

Discover essential business fundamentals and corporate details for Acutus Medical, Inc. (AFIB) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

6 Aug 2020

Employees

85.00

CEO

Takeo Mukai

Description

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

AFIB Financial Timeline

Browse a chronological timeline of Acutus Medical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 3 Apr 2025

Earnings released on 24 Mar 2025

EPS came in at -$0.05 , while revenue for the quarter reached $7.14M .

Earnings released on 14 Nov 2024

EPS came in at -$0.03 , while revenue for the quarter reached $5.27M .

Earnings released on 8 Aug 2024

EPS came in at -$0.01 , while revenue for the quarter reached $4.13M .

Earnings released on 9 May 2024

EPS came in at -$0.07 , while revenue for the quarter reached $3.63M .

Earnings released on 1 Apr 2024

EPS came in at -$1.15 falling short of the estimated -$0.39 by -193.08%, while revenue for the quarter reached -$7.53M , missing expectations by -213.60%.

Earnings released on 8 Nov 2023

EPS came in at -$0.45 surpassing the estimated -$0.57 by +21.05%, while revenue for the quarter reached $5.24M , missing expectations by -21.00%.

Earnings released on 7 Aug 2023

EPS came in at -$0.63 falling short of the estimated -$0.61 by -3.28%, while revenue for the quarter reached $5.29M , beating expectations by +16.75%.

Earnings released on 11 May 2023

EPS came in at -$0.57 surpassing the estimated -$0.66 by +13.64%, while revenue for the quarter reached $1.24M , missing expectations by -67.74%.

Earnings released on 16 Mar 2023

EPS came in at $0.41 surpassing the estimated -$0.71 by +157.75%, while revenue for the quarter reached $4.96M , beating expectations by +14.86%.

Earnings released on 10 Nov 2022

EPS came in at -$0.72 surpassing the estimated -$0.83 by +13.25%, while revenue for the quarter reached $3.64M , missing expectations by -0.63%.

Earnings released on 11 Aug 2022

EPS came in at $0.16 surpassing the estimated -$0.83 by +119.28%, while revenue for the quarter reached $4.08M , beating expectations by +6.19%.

Earnings released on 12 May 2022

EPS came in at -$1.00 falling short of the estimated -$0.99 by -1.01%, while revenue for the quarter reached $3.68M , beating expectations by +17.66%.

Earnings released on 30 Mar 2022

EPS came in at -$1.00 falling short of the estimated -$0.92 by -8.70%, while revenue for the quarter reached $4.36M , beating expectations by +3.48%.

Earnings released on 11 Nov 2021

EPS came in at -$0.87 surpassing the estimated -$0.92 by +5.43%, while revenue for the quarter reached $4.60M , beating expectations by +8.24%.

Earnings released on 12 Aug 2021

EPS came in at -$0.89 surpassing the estimated -$1.00 by +11.00%, while revenue for the quarter reached $4.71M , beating expectations by +8.25%.

Earnings released on 12 May 2021

EPS came in at -$0.97 falling short of the estimated -$0.70 by -38.57%, while revenue for the quarter reached $3.59M , beating expectations by +39.66%.

Earnings released on 18 Mar 2021

EPS came in at -$0.89 falling short of the estimated -$0.71 by -25.35%, while revenue for the quarter reached $2.57M .

Earnings released on 12 Nov 2020

EPS came in at -$0.91 surpassing the estimated -$1.11 by +18.02%, while revenue for the quarter reached $3.17M , beating expectations by +17.06%.

Earnings released on 17 Sept 2020

EPS came in at -$32.24 falling short of the estimated -$1.03 by -3.03K%, while revenue for the quarter reached $1.13M , beating expectations by +1.21K%.

AFIB Stock Performance

Access detailed AFIB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run